• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News & stories

Statements

Home > News & stories

Statements

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2025

Results

No results found. Please try using different filter option(s).

Healthcare worker attending a training
Press Releases Translations
10 Jul 2025

Un nouveau projet en RDC vise à améliorer l’accès aux soins des personnes atteintes de la maladie à VIH à un stade avancé

Healthcare worker attending a training
Press releases
10 Jul 2025

New HIV project in the DRC brings life-saving care closer to people with advanced HIV disease

Woman working in a laboratory
News
10 Jul 2025

LEO Foundation partners with DNDi to develop breakthrough drug discovery model for mycetoma 

In the media
4 Jul 2025

New drug to be registered with FDA

Bangkok Post
Press releases
1 Jul 2025

Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment  

Young boy in front of a house in rural village
Publications
27 Jun 2025

2024 DNDi Financial Report

In the media
26 Jun 2025

¿Qué es la enfermedad de chagas? Habla hombre que resucitó tras padecerla

Los Informantes
Scientific articles
26 Jun 2025

Validated LC-MS/MS method for quantifying the antiparasitic nitroimidazole DNDI-0690 in preclinical target site PK/PD studies

Biomedical Chromatography
Nature logo
In the media
25 Jun 2025

First all-oral treatment for deadly strain of sleeping sickness now available in Africa

Nature
BMJ Innovations logo
In the media
17 Jun 2025

Can the use of AI in the pharmaceutical sector deliver new medicines, not new risks?

BMJ Innovations
In the media
17 Jun 2025

Serum Institute signs MoU with DNDi to develop dengue treatment candidate

Business Standard
In the media
17 Jun 2025

‘Timely’ alliance to develop effective dengue treatment

The Sun
ET Pharma logo
In the media
14 Jun 2025

Serum Institute to conduct Brazilian trials of late-stage dengue candidate with DNDi

ET Pharma
In the media
14 Jun 2025

Serum, DNDi to develop affordable dengue treatment

Hindustan Times
The Hindu logo
In the media
14 Jun 2025

SII, DNDi partner for expanding human trials for dengue treatment

The Hindu
Press Trust of India logo
In the media
13 Jun 2025

Serum, DNDi join hands to fast-track development of new treatment for dengue

Press Trust of India
loading
Loading...
Statements
27 May 2025

DNDi interventions at the 78th World Health Assembly

Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Statements
12 Feb 2025

DNDi statement on recent US government executive actions and the escalating retreat from global health and medical research

Statements
5 Feb 2025

DNDi interventions at the 156th Session of the WHO Executive Board

Statements
24 Jan 2025

DNDi’s briefing note for 156th Session of the WHO Executive Board

Statements
30 Oct 2024

DNDi interventions at the 5th Meeting of the G20 Health Working Group and G20 Health Ministerial Meeting, 30-31 October 2024

Statements
31 Jul 2024

DNDi submission to Global Goal on Adaptation UAE-Belem Work programme on Indicators for UAE Framework for Global Climate Resilience

Statements
24 Jul 2024

DNDi response to Request for Information on draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning

Statements
28 May 2024

DNDi interventions at the 77th World Health Assembly

Statements
21 May 2024

DNDi’s briefing note for 77th World Health Assembly

Statements
25 Apr 2024

DNDi comments on WHO Pandemic Agreement – Recommendations for Article 9: Research and Development

Statements
8 Apr 2024

DNDi submission to Global Goal on Adaptation

Statements
18 Mar 2024

Ninth meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response

Statements
19 Feb 2024

Eighth meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response

Statements
26 Jan 2024

DNDi interventions at the 154th Session of the WHO Executive Board

1 2 … 5 ›

Connect and share

Follow us on social media to stay updated and help us share the stories of neglected patients.  

Linkedin Instagram Twitter Facebook Youtube
EM PORTUGUÊS
EN ESPAÑOL
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License